Industry News
Ora and Singapore Eye Research Institute Partner to Advance Ophthalmic Research

Contract Research Organization (CRO) Ora Inc. announced a new strategic partnership with the Singapo...

read more
Ora and Singapore Eye Research Institute Partner to Advance Ophthalmic Research
May 07, 2024
Lumibird Introduces C.DIAG: Novel Dry Eye Diagnostic Aid Platform

Lumibird Medical has unveiled its latest innovation, the C.DIAG, marking a significant advancement i...

read more
Lumibird Introduces C.DIAG: Novel Dry Eye Diagnostic Aid Platform
May 06, 2024
FDA Accepts Eluminex’s IND Application for Trispecific Fusion Antibody for DME

Eluminex Biosciences announced the acceptance of its EB-105 Investigational New Drug (IND) applicati...

read more
FDA Accepts Eluminex’s IND Application for Trispecific Fusion Antibody for DME
May 06, 2024
Emmetrope Ophthalmics Completes Dosing in Key Corneal Edema Trial

Emmetrope Ophthalmics, a leader in cell-based therapies for severe eye diseases, today announced the...

read more
Emmetrope Ophthalmics Completes Dosing in Key Corneal Edema Trial
May 02, 2024
Aurion Biotech Completes Enrollment in Corneal Edema Clinical Trial

Aurion Biotech has officially completed the dosing of all participants in its phase 1/2 clinical tri...

read more
Aurion Biotech Completes Enrollment in Corneal Edema Clinical Trial
May 02, 2024
RetiSpec and Topcon Announce Collaboration on Eye-Based AI Diagnostic Tool

Topcon Healthcare has announced an investment in RetiSpec, marking the beginning of a collaboration ...

read more
RetiSpec and Topcon Announce Collaboration on Eye-Based AI Diagnostic Tool
May 02, 2024
Inflammasome Therapeutics Initiates Clinical Trial for Geographic Atrophy Treatment

Inflammasome Therapeutics has officially dosed the first patient in a pioneering clinical trial aime...

read more
Inflammasome Therapeutics Initiates Clinical Trial for Geographic Atrophy Treatment
April 30, 2024
Topcon Healthcare Names Ali Tafreshi as President and CEO

In a significant leadership shift, Topcon Healthcare announced Ali Tafreshi as its new President and...

read more
Topcon Healthcare Names Ali Tafreshi as President and CEO
April 30, 2024
Naegis Pharma Secures Funding to Advance Ophthalmic Drug for Eye Diseases

Naegis Pharmaceuticals Inc., a life sciences company specializing in inflammation and ophthalmology,...

read more
Naegis Pharma Secures Funding to Advance Ophthalmic Drug for Eye Diseases
April 29, 2024
LVPEI and CORE Form Strategic Alliance to Advance Global Eye Care and Vision Science

L.V. Prasad Eye Institute (LVPEI) and the Centre for Ocular Research & Education (CORE) at the Unive...

read more
LVPEI and CORE Form Strategic Alliance to Advance Global Eye Care and Vision Science
April 29, 2024
More